Defining decision-grade real-world evidence and its role in the Canadian context: A design sprint Summary report of a workshop

This report provides a summary of a real-world evidence (RWE) design sprint workshop that took place on October 21, 2018 in Toronto, Ontario. The workshop was developed and delivered as a joint partnership between the Canadian Agency for Drugs and Technologies in Health (CADTH); Canadian Association for Population Therapeutics (CAPT), Health Canada, and the Institute of Health Economics (IHE). The intent of the workshop was to identify key opportunities for RWE to support decision-making throughout the pharmaceutical product life cycle, as well as the evidence standards required to be considered decision-grade.

Publication Type: Summary Reports

Year of Publication: 2018

Topics: Other, Pharmaceuticals

Authors: Dan Palfrey

ISBN (online): 978-1-926929-93-4